The Endocrine Society now issued a Clinical Practice Guideline (CPG) advising against using testosterone therapy in healthy women. Although the FDA approved testosterone therapy for the treatment of diseases involving the testes, pituitary and hypothalamus, it hasn't been approved for treating age-related decrease in testosterone levels. The U.S. National Institute on Aging is also anticipated to release the results of research on the security of testosterone. The study included about 800 elderly men with low testosterone and symptoms associated with this condition, including http://tinyurl.com/zwvtvex
physical and sexual dysfunction. The research is expected to shed more light on the security of testosterone treatment, since the men's heart
health was carefully monitored.
The recent conflicting findings on testosterone therapy prompted his team to conduct a substantial systematic literature search for studies assessing the relationship between testosterone replacement therapy and cardiovascular events among guys and Patel. An estimated 13 million men in America suffer with low testosterone, which occurs when the body fails to make enough hormones because of a difficulty with the testicles or pituitary gland. This explains apparent aging, a person's unexpected weight gain and decline of energy.
And many girls have a knee jerk suspicion that any hormone treatment can increase their risk of breast cancer. However, clinical studies show that testosterone not only does not increase a woman's risk
of breast cancer , it may play a key role in warding off the disease. Glaser believes this will probably stay the status quo for a while, given the prohibitive cost of running the long term safety studies needed to gain completer FDA acceptance.